{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:29:29Z","timestamp":1744172969797,"version":"3.40.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Environ Biophys"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00411-020-00879-2","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T15:02:41Z","timestamp":1604070161000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-1851","authenticated-orcid":false,"given":"Tomas","family":"Radivoyevitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"8","key":"879_CR1","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/21645515.2018.1462639","volume":"14","author":"JD Allen","year":"2018","unstructured":"Allen JD, Ross TM (2018) H3N2 influenza viruses in humans: viral mechanisms, evolution, and evaluation. Hum Vaccin Immunother 14(8):1840\u20131847. https:\/\/doi.org\/10.1080\/21645515.2018.1462639","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"879_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s11538-017-0272-7","volume":"80","author":"A Besse","year":"2018","unstructured":"Besse A, Clapp GD, Bernard S, Nicolini FE, Levy D, Lepoutre T (2018) Stability analysis of a model of interaction between the immune system and cancer cells in chronic myelogenous leukemia. Bull Math Biol 80(5):1084\u20131110. https:\/\/doi.org\/10.1007\/s11538-017-0272-7","journal-title":"Bull Math Biol"},{"issue":"8","key":"879_CR3","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","volume":"86","author":"C Biernaux","year":"1995","unstructured":"Biernaux C, Loos M, Sels A, Huez G, Stryckmans P (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86(8):3118\u20133122","journal-title":"Blood"},{"issue":"6","key":"879_CR4","first-page":"1295","volume":"79","author":"JD Boice Jr","year":"1987","unstructured":"Boice JD Jr, Blettner M, Kleinerman RA, Stovall M, Moloney WC, Engholm G, Austin DF, Bosch A, Cookfair DL, Krementz ET (1987) Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst 79(6):1295\u20131311","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"879_CR5","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","volume":"92","author":"S Bose","year":"1998","unstructured":"Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV (1998) The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92(9):3362\u20133367","journal-title":"Blood"},{"issue":"7","key":"879_CR6","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11538-019-00608-x","volume":"81","author":"A Cesar Fassoni","year":"2019","unstructured":"Cesar Fassoni A, Roeder I, Glauche I (2019) To cure or not to cure: consequences of immunological interactions in CML treatment. Bull Math Biol 81(7):2345\u20132395. https:\/\/doi.org\/10.1007\/s11538-019-00608-x","journal-title":"Bull Math Biol"},{"issue":"Suppl 2","key":"879_CR7","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","volume":"94","author":"B Chereda","year":"2015","unstructured":"Chereda B, Melo JV (2015) Natural course and biology of CML. Ann Hematol 94(Suppl 2):S107-121. https:\/\/doi.org\/10.1007\/s00277-015-2325-z","journal-title":"Ann Hematol"},{"issue":"19","key":"879_CR8","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1158\/0008-5472.CAN-15-0611","volume":"75","author":"GD Clapp","year":"2015","unstructured":"Clapp GD, Lepoutre T, El Cheikh R, Bernard S, Ruby J, Labussiere-Wallet H, Nicolini FE, Levy D (2015) Implication of the autologous immune system in BCR-ABL transcript variations in chronic myelogenous leukemia patients treated with imatinib. Cancer Res 75(19):4053\u20134062. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0611","journal-title":"Cancer Res"},{"key":"879_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.leukres.2017.03.003","volume":"57","author":"RP Gale","year":"2017","unstructured":"Gale RP, Opelz G (2017) Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much. Leuk Res 57:109\u2013111. https:\/\/doi.org\/10.1016\/j.leukres.2017.03.003","journal-title":"Leuk Res"},{"issue":"8","key":"879_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0145-2126(00)00038-2","volume":"24","author":"RP Gale","year":"2000","unstructured":"Gale RP, Cozen W, Goodman MT, Wang FF, Bernstein L (2000) Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles county. Leuk Res 24(8):665\u2013669","journal-title":"Leuk Res"},{"issue":"6","key":"879_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N, Jamieson L, Vyas P, Anderson K, Segerstolpe A, Qian H, Olsson-Stromberg U, Mustjoki S, Sandberg R, Jacobsen SEW, Mead AJ (2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23(6):692\u2013702. https:\/\/doi.org\/10.1038\/nm.4336","journal-title":"Nat Med"},{"key":"879_CR12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"879_CR13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2175","author":"T Hahnel","year":"2020","unstructured":"Hahnel T, Baldow C, Guilhot J, Guilhot F, Saussele S, Mustjoki S, Jilg S, Jost PJ, Dulucq S, Mahon FX, Roeder I, Fassoni AC, Glauche I (2020) Model-based inference and classification of immunological control mechanisms from TKI cessation and dose reduction in CML patients. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2175","journal-title":"Cancer Res"},{"issue":"24","key":"879_CR14","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1073\/pnas.1922884117","volume":"117","author":"Y Higuchi","year":"2020","unstructured":"Higuchi Y, Yasunaga JI, Mitagami Y, Tsukamoto H, Nakashima K, Ohshima K, Matsuoka M (2020) HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling. Proc Natl Acad Sci USA 117(24):13740\u201313749. https:\/\/doi.org\/10.1073\/pnas.1922884117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"879_CR15","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78(10):6476\u20136480. https:\/\/doi.org\/10.1073\/pnas.78.10.6476","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"879_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1667\/RR2892.1","volume":"179","author":"WL Hsu","year":"2013","unstructured":"Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, Iwanaga M, Miyazaki Y, Cullings HM, Suyama A, Ozasa K, Shore RE, Mabuchi K (2013) The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950\u20132001. Radiat Res 179(3):361\u2013382. https:\/\/doi.org\/10.1667\/RR2892.1","journal-title":"Radiat Res"},{"issue":"1","key":"879_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2016-01-694265","volume":"128","author":"TP Hughes","year":"2016","unstructured":"Hughes TP, Ross DM (2016) Moving treatment-free remission into mainstream clinical practice in CML. Blood 128(1):17\u201323. https:\/\/doi.org\/10.1182\/blood-2016-01-694265","journal-title":"Blood"},{"issue":"1","key":"879_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2307\/3578404","volume":"135","author":"PD Inskip","year":"1993","unstructured":"Inskip PD, Kleinerman RA, Stovall M, Cookfair DL, Hadjimichael O, Moloney WC, Monson RR, Thompson WD, Wactawski-Wende J, Wagoner JK (1993) Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res 135(1):108\u2013124","journal-title":"Radiat Res"},{"issue":"2","key":"879_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cellimm.2015.02.001","volume":"294","author":"TN Jorgensen","year":"2015","unstructured":"Jorgensen TN (2015) Sex disparities in the immune response. Cell Immunol 294(2):61\u201362. https:\/\/doi.org\/10.1016\/j.cellimm.2015.02.001","journal-title":"Cell Immunol"},{"issue":"6","key":"879_CR20","doi-asserted-by":"publisher","first-page":"e1000095","DOI":"10.1371\/journal.pcbi.1000095","volume":"4","author":"PS Kim","year":"2008","unstructured":"Kim PS, Lee PP, Levy D (2008) Dynamics and potential impact of the immune response to chronic myelogenous leukemia. PLoS Comp Biol 4(6):e1000095. https:\/\/doi.org\/10.1371\/journal.pcbi.1000095","journal-title":"PLoS Comp Biol"},{"issue":"7","key":"879_CR21","doi-asserted-by":"publisher","first-page":"e0008361","DOI":"10.1371\/journal.pntd.0008361","volume":"14","author":"D Kodama","year":"2020","unstructured":"Kodama D, Tanaka M, Matsuzaki T, Izumo K, Nakano N, Matsuura E, Saito M, Nagai M, Horiuchi M, Utsunomiya A, Takashima H, Kubota R, Izumo S (2020) Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS Negl Trop Dis 14(7):e0008361. https:\/\/doi.org\/10.1371\/journal.pntd.0008361","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"879_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.celrep.2016.09.068","volume":"17","author":"FJ Kohlhapp","year":"2016","unstructured":"Kohlhapp FJ, Huelsmann EJ, Lacek AT, Schenkel JM, Lusciks J, Broucek JR, Goldufsky JW, Hughes T, Zayas JP, Dolubizno H, Sowell RT, Kuhner R, Burd S, Kubasiak JC, Nabatiyan A, Marshall S, Bommareddy PK, Li S, Newman JH, Monken CE, Shafikhani SH, Marzo AL, Guevara-Patino JA, Lasfar A, Thomas PG, Lattime EC, Kaufman HL, Zloza A (2016) Non-oncogenic acute viral infections disrupt anti-cancer responses and lead to accelerated cancer-specific host death. Cell Rep 17(4):957\u2013965. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.068","journal-title":"Cell Rep"},{"issue":"7724","key":"879_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","volume":"561","author":"H Lee-Six","year":"2018","unstructured":"Lee-Six H, Obro NF, Shepherd MS, Grossmann S, Dawson K, Belmonte M, Osborne RJ, Huntly BJP, Martincorena I, Anderson E, O\u2019Neill L, Stratton MR, Laurenti E, Green AR, Kent DG, Campbell PJ (2018) Population dynamics of normal human blood inferred from somatic mutations. Nature 561(7724):473\u2013478. https:\/\/doi.org\/10.1038\/s41586-018-0497-0","journal-title":"Nature"},{"issue":"4","key":"879_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3109\/10428194.2013.827785","volume":"55","author":"V Mak","year":"2014","unstructured":"Mak V, Ip D, Mang O, Dalal C, Huang S, Gerrie A, Gillan T, Ramadan KM, Toze C, Au WY (2014) Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008. Leuk Lymphoma 55(4):824\u2013827. https:\/\/doi.org\/10.3109\/10428194.2013.827785","journal-title":"Leuk Lymphoma"},{"key":"879_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-4690-2-27","volume":"2","author":"M Matsuoka","year":"2005","unstructured":"Matsuoka M (2005) Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2:27. https:\/\/doi.org\/10.1186\/1742-4690-2-27","journal-title":"Retrovirology"},{"issue":"1","key":"879_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12977-020-0511-0","volume":"17","author":"M Matsuoka","year":"2020","unstructured":"Matsuoka M, Mesnard JM (2020) HTLV-1 bZIP factor: the key viral gene for pathogenesis. Retrovirology 17(1):2. https:\/\/doi.org\/10.1186\/s12977-020-0511-0","journal-title":"Retrovirology"},{"issue":"4","key":"879_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jtbi.2003.11.024","volume":"227","author":"H Moore","year":"2004","unstructured":"Moore H, Li NK (2004) A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction. J of Theor Biol 227(4):513\u2013523. https:\/\/doi.org\/10.1016\/j.jtbi.2003.11.024","journal-title":"J of Theor Biol"},{"key":"879_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0647-x","author":"IS Pagani","year":"2019","unstructured":"Pagani IS, Dang P, Saunders VA, Grose R, Shanmuganathan N, Kok CH, Carne L, Rwodzi Z, Watts S, McLean J, Braley J, Altamura H, Yeung DT, Branford S, Yong ASM, White DL, Hughes TP, Ross DM (2019) Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission. Leukemia. https:\/\/doi.org\/10.1038\/s41375-019-0647-x","journal-title":"Leukemia"},{"issue":"9","key":"879_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1023\/A:1020608328969","volume":"13","author":"JW Pan","year":"2002","unstructured":"Pan JW, Cook LS, Schwartz SM, Weis NS (2002) Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control 13(9):791\u2013795","journal-title":"Cancer Causes Control"},{"issue":"5","key":"879_CR30","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11538-010-9553-0","volume":"73","author":"D Paquin","year":"2011","unstructured":"Paquin D, Kim PS, Lee PP, Levy D (2011) Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia. Bull Math Biol 73(5):1082\u20131100. https:\/\/doi.org\/10.1007\/s11538-010-9553-0","journal-title":"Bull Math Biol"},{"issue":"5","key":"879_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-15-1423","volume":"76","author":"JT Poleszczuk","year":"2016","unstructured":"Poleszczuk JT, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H (2016) Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions. Cancer Res 76(5):1009\u20131018. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1423","journal-title":"Cancer Res"},{"issue":"2 Suppl","key":"879_CR32","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2307\/3578893","volume":"137","author":"DL Preston","year":"1994","unstructured":"Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T (1994) Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987. Radiat Res 137(2 Suppl):S68\u2013S97","journal-title":"Radiat Res"},{"issue":"1\u20132","key":"879_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0025-5564(99)00039-5","volume":"162","author":"T Radivoyevitch","year":"1999","unstructured":"Radivoyevitch T, Hoel DG (1999) Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data. Math Biosci 162(1\u20132):85\u2013101","journal-title":"Math Biosci"},{"issue":"3","key":"879_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s004110000055","volume":"39","author":"T Radivoyevitch","year":"2000","unstructured":"Radivoyevitch T, Hoel DG (2000) Biologically-based risk estimation for radiation-induced chronic myeloid leukemia. Radiat Environ Biophys 39(3):153\u2013159","journal-title":"Radiat Environ Biophys"},{"issue":"3","key":"879_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s004110050156","volume":"38","author":"T Radivoyevitch","year":"1999","unstructured":"Radivoyevitch T, Ramsey MJ, Tucker JD (1999) Estimation of the target stem-cell population size in chronic myeloid leukemogenesis. Radiat Environ Biophys 38(3):201\u2013206","journal-title":"Radiat Environ Biophys"},{"issue":"1","key":"879_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004110100088","volume":"40","author":"T Radivoyevitch","year":"2001","unstructured":"Radivoyevitch T, Kozubek S, Sachs RK (2001) Biologically based risk estimation for radiation-induced CML. Inferences from BCR and ABL geometric distributions. Radiat Environ Biophys 40(1):1\u20139","journal-title":"Radiat Environ Biophys"},{"issue":"1","key":"879_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1667\/0033-7587(2002)157[0106:TROCML]2.0.CO;2","volume":"157","author":"T Radivoyevitch","year":"2002","unstructured":"Radivoyevitch T, Kozubek S, Sachs RK (2002) The risk of chronic myeloid leukemia: can the dose-response curve be U- shaped? Radiat Res 157(1):106\u2013109","journal-title":"Radiat Res"},{"issue":"19","key":"879_CR38","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1182\/blood-2011-09-381855","volume":"119","author":"T Radivoyevitch","year":"2012","unstructured":"Radivoyevitch T, Hlatky L, Landaw J, Sachs RK (2012) Quantitative modeling of chronic myeloid leukemia: insights from radiobiology. Blood 119(19):4363\u20134371. https:\/\/doi.org\/10.1182\/blood-2011-09-381855","journal-title":"Blood"},{"issue":"1","key":"879_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00411-013-0507-4","volume":"53","author":"T Radivoyevitch","year":"2014","unstructured":"Radivoyevitch T, Jankovic GM, Tiu RV, Saunthararajah Y, Jackson RC, Hlatky LR, Gale RP, Sachs RK (2014) Sex differences in the incidence of chronic myeloid leukemia. Radiat Environ Biophys 53(1):55\u201363. https:\/\/doi.org\/10.1007\/s00411-013-0507-4","journal-title":"Radiat Environ Biophys"},{"key":"879_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.leukres.2019.02.003","volume":"79","author":"T Radivoyevitch","year":"2019","unstructured":"Radivoyevitch T, Jorgensen TN, Lindner DJ, Maciejewski JP, Miyazaki Y, Gale RP (2019) Chronic myeloid leukemia: two mysteries. Leuk Res 79:3\u20135. https:\/\/doi.org\/10.1016\/j.leukres.2019.02.003","journal-title":"Leuk Res"},{"issue":"4","key":"879_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/oxfordjournals.molbev.a003846","volume":"18","author":"S Van Dooren","year":"2001","unstructured":"Van Dooren S, Salemi M, Vandamme AM (2001) Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes. Mol Biol Evol 18(4):661\u2013671. https:\/\/doi.org\/10.1093\/oxfordjournals.molbev.a003846","journal-title":"Mol Biol Evol"}],"container-title":["Radiation and Environmental Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-020-00879-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00411-020-00879-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-020-00879-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:38:22Z","timestamp":1744151902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00411-020-00879-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s00411-020-00879-2","relation":{},"ISSN":["0301-634X","1432-2099"],"issn-type":[{"type":"print","value":"0301-634X"},{"type":"electronic","value":"1432-2099"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}